Ophra Rebiere

Ophra Rebiere is a physician by training and received her PhD on General Pharmacology degree from Université Paris Diderot (Paris7) She held several key positions across marketing, sales, and R&D in Aventis, then in Sanofi. Her diverse experiences included Head of the Antibiotics and Allergy Business Unit at the French affiliate, Vice President Marketing and Sales Force Excellence for the Intercontinental Region and Global Project Leader in R&D. In 2005, Dr Rebiere became Global Franchise Head in Diabetes and Metabolism for several years in charge of Insulins and preparing the launch of Rimonabant. She took then a transverse position on Business transformation, including emerging functions such as Market access and digital inclusion into global and countries practices. In 2010, she worked closely with R&D and Business development on the “New products”. In her last position, Ophra Rebiere was Global Brand Team Leader for Praluent, in charge of designing and driving the brand strategy, uniting talents and energies around new working principles. Since June 1st 2016 Ophra Rebiere is Head of Corporate Social Responsibility (CSR) in charge with her team to define and deploy a focused global CSR Strategy, ensuring that evolving regulatory, legal, and normative obligations are addressed by the appropriate processes, prioritizing sanofi CSR mobilization themes and programs focusing on the underserved population especially in Public Health needs and with outcome measures, supporting our communities where we operate and working closely with our key stakeholders.